(1)Each organization, practice, or
pharmacy that receives a grant through the pilot program shall submit an annual
report to the center by a date set by the center. At a minimum, the report must
include the following information:
(a)The amount of the grant and the date on which the grant was received;
(b)An accounting of how the grant money was spent and whether any grant
money was not expended;
(c)The number of nurse practitioners, physician assistants, or pharmacists
who were trained; and who received certification to prescribe buprenorphine and all
other medications and therapies approved by the federal food and drug
administration to treat opioid use disorder;
(d)A detailed description of the training received by nurse practitioners or
physician assistants; whether the
Free access — add to your briefcase to read the full text and ask questions with AI
(1) Each organization, practice, or
pharmacy that receives a grant through the pilot program shall submit an annual
report to the center by a date set by the center. At a minimum, the report must
include the following information:
(a) The amount of the grant and the date on which the grant was received;
(b) An accounting of how the grant money was spent and whether any grant
money was not expended;
(c) The number of nurse practitioners, physician assistants, or pharmacists
who were trained; and who received certification to prescribe buprenorphine and all
other medications and therapies approved by the federal food and drug
administration to treat opioid use disorder;
(d) A detailed description of the training received by nurse practitioners or
physician assistants; whether the nurse practitioners or physician assistants
completed the training and attained status as a qualified nurse practitioner or
physician assistant; whether the nurse practitioners or physician assistants that
attained qualified nurse practitioner or physician assistant status are currently able
to provide and are providing medication-assisted treatment to opioid-dependent
patients; the number of individuals with opioid use disorders treated in the previous
two years before the pilot program; and the number of opioid-dependent patients
treated during the pilot program period by each qualified nurse practitioner or
physician assistant; and
(e) A detailed description of the training received by pharmacists; whether
the pharmacists who received training are currently able to provide and are
providing medication-assisted treatment to opioid-dependent patients; and the
number of opioid-dependent patients treated during the pilot program period by
each pharmacist.
(2) The center shall annually submit a summarized report on the pilot
program to the health and human services committee of the senate and the health
and insurance and the public health care and human services committees of the
house of representatives, or any successor committees, and to the governor. At a
minimum, the report must include:
(a) A description of the pilot program, including a list of counties
participating in the pilot program;
(b) A list identifying the grant recipients, including the amount awarded to
each grant recipient, the county in which the grant recipient is providing services,
and a detailed description of how each grant recipient used the grant award;
(c) Repealed.
(d) The total number of patients served during the course of the pilot
program, listed by county participating in the pilot program;
(e) A summary of policies and procedures instituted by grant recipients
related to the provision of MAT by qualified nurse practitioners, physician
assistants, and pharmacists;
(f) A summary of evaluation results of the pilot program; and
(g) A summary of lessons learned and recommendations for implementing
MAT as provided by nurse practitioners, physician assistants, and pharmacists in
other communities in the state.